Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20,570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY.
Naik S, Wong R, Arai S, Brown J, Laport G, Lowsky R, Miklos D, Shizuru J, Blume K, Negrin R, Johnston L. Naik S, et al. Among authors: brown j. Bone Marrow Transplant. 2011 Feb;46(2):192-9. doi: 10.1038/bmt.2010.114. Epub 2010 May 24. Bone Marrow Transplant. 2011. PMID: 20498648 Free PMC article.
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.
Arai S, Sahaf B, Narasimhan B, Chen GL, Jones CD, Lowsky R, Shizuru JA, Johnston LJ, Laport GG, Weng WK, Benjamin JE, Schaenman J, Brown J, Ramirez J, Zehnder JL, Negrin RS, Miklos DB. Arai S, et al. Among authors: brown j. Blood. 2012 Jun 21;119(25):6145-54. doi: 10.1182/blood-2011-12-395970. Epub 2012 May 4. Blood. 2012. PMID: 22563089 Free PMC article. Clinical Trial.
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation.
Johnston L, Florek M, Armstrong R, McCune JS, Arai S, Brown J, Laport G, Lowsky R, Miklos D, Shizuru J, Sheehan K, Lavori P, Negrin R. Johnston L, et al. Among authors: brown j. Bone Marrow Transplant. 2012 Apr;47(4):581-8. doi: 10.1038/bmt.2011.104. Epub 2011 May 9. Bone Marrow Transplant. 2012. PMID: 21552302 Free PMC article.
Real-World Experience of Cryopreserved Allogeneic Hematopoietic Grafts during the COVID-19 Pandemic: A Single-Center Report.
Bankova AK, Caveney J, Yao B, Ramos TL, Bögeholz J, Heydari K, Diaz N, Jackson ML, Lowsky R, Brown JW, Johnston L, Rezvani AR, Frank MJ, Muffly L, Weng WK, Sidana S, Negrin RS, Miklos DB, Shiraz P, Meyer EH, Shizuru JA, Arai S. Bankova AK, et al. Among authors: brown jw. Transplant Cell Ther. 2022 Apr;28(4):215.e1-215.e10. doi: 10.1016/j.jtct.2022.01.010. Epub 2022 Jan 15. Transplant Cell Ther. 2022. PMID: 35042013 Free PMC article.
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ. Johnston LJ, et al. Among authors: brown j. Biol Blood Marrow Transplant. 2005 Jan;11(1):47-55. doi: 10.1016/j.bbmt.2004.10.004. Biol Blood Marrow Transplant. 2005. PMID: 15625544 Free article. Clinical Trial.
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma.
Baird JH, Epstein DJ, Tamaresis JS, Ehlinger Z, Spiegel JY, Craig J, Claire GK, Frank MJ, Muffly L, Shiraz P, Meyer E, Arai S, Brown JW, Johnston L, Lowsky R, Negrin RS, Rezvani AR, Weng WK, Latchford T, Sahaf B, Mackall CL, Miklos DB, Sidana S. Baird JH, et al. Among authors: brown jw. Blood Adv. 2021 Jan 12;5(1):143-155. doi: 10.1182/bloodadvances.2020002732. Blood Adv. 2021. PMID: 33570626 Free PMC article.
20,570 results
You have reached the last available page of results. Please see the User Guide for more information.